Variance in the identification of microRNAs deregulated in Alzheimer's disease and possible role of lincRNAs in the pathology: The need of larger datasets

Ageing Research Reviews

Volumn 17, Issue , 2014, Pages 43-53

  Lau, Pierre ^a,b   Sala Frigerio, Carlo ^a,b   De Strooper, Bart ^a,b,c  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Long non coding RNA; MicroRNA; MiR 132

Indexed keywords

COMPLEMENTARY RNA; LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 132; TAU PROTEIN; BIOLOGICAL MARKER; MIRN132 MICRORNA, HUMAN;

ALZHEIMER DISEASE; CELL SURVIVAL; CONSENSUS; DOWN REGULATION; GENE EXPRESSION REGULATION; HIGH THROUGHPUT SEQUENCING; HUMAN; NEUROPATHOLOGY; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; RNA ANALYSIS; SIGNAL TRANSDUCTION; ANIMAL; BLOOD; METABOLISM; NERVE CELL;

ALZHEIMER DISEASE; ANIMALS; BIOLOGICAL MARKERS; CELL SURVIVAL; HUMANS; MICRORNAS; NEURONS; RNA, LONG NONCODING; TAU PROTEINS;

EID: 84906791239     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2014.02.006     Document Type: Review

References (68)

1. Alvarez-Saavedra M., Antoun G., Yanagiya A., Oliva-Hernandez R., Cornejo-Palma D., Perez-Iratxeta C., Sonenberg N., Cheng H.Y. miRNA-132 orchestrates chromatin remodeling and translational control of the circadian clock. Human Molecular Genetics 2011, 20:731-751.
2. Alzheimer A., Stelzmann R.A., Schnitzlein H.N., Murtagh F.R. An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde. Clinical Anatomy (New York, N.Y.) 1995, 8:429-431.
3. Arisi I., D'Onofrio M., Brandi R., Felsani A., Capsoni S., Drovandi G., Felici G., Weitschek E., Bertolazzi P., Cattaneo A. Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection. Journal of Alzheimer's disease: JAD 2011, 24:721-738.
4. Arroyo J.D., Chevillet J.R., Kroh E.M., Ruf I.K., Pritchard C.C., Gibson D.F., Mitchell P.S., Bennett C.F., Pogosova-Agadjanyan E.L., Stirewalt D.L., Tait J.F., Tewari M. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:5003-5008.
5. Baraniskin A., Kuhnhenn J., Schlegel U., Maghnouj A., Zollner H., Schmiegel W., Hahn S., Schroers R. Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma. Neuro Oncology 2011, 14:29-33.
6. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
7. Bekris L.M., Lutz F., Montine T.J., Yu C.E., Tsuang D., Peskind E.R., Leverenz J.B. MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma. Biomarkers 2013, 18:455-466.
8. Bettens K., Sleegers K., Van Broeckhoven C. Genetic insights in Alzheimer's disease. Lancet Neurology 2013, 12:92-104.
9. Blalock E.M., Geddes J.W., Chen K.C., Porter N.M., Markesbery W.R., Landfield P.W. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:2173-2178.
10. Boudreau R.L., Jiang P., Gilmore B.L., Spengler R.M., Tirabassi R., Nelson J.A., Ross C.A., Xing Y., Davidson B.L. Transcriptome-wide discovery of microRNA binding sites in human brain. Neuron 2014, 81:294-305.
11. Braak H., Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiology of Aging 1995, 16:271-278. (discussion 278-284).
12. Cabili M.N., Trapnell C., Goff L., Koziol M., Tazon-Vega B., Regev A., Rinn J.L. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes & Development 2011, 25:1915-1927.
13. Chen G., Qiu C., Zhang Q., Liu B., Cui Q. Genome-wide analysis of human SNPs at long intergenic noncoding RNAs. Human Mutation 2013, 34:338-344.
14. Ciarlo E., Massone S., Penna I., Nizzari M., Gigoni A., Dieci G., Russo C., Florio T., Cancedda R., Pagano A. An intronic ncRNA-dependent regulation of SORL1 expression affecting Abeta formation is upregulated in post-mortem Alzheimer's disease brain samples. Disease Models & Mechanisms 2013, 6:424-433.
15. Clovis Y.M., Enard W., Marinaro F., Huttner W.B., De Pietri Tonelli D. Convergent repression of Foxp2 3'UTR by miR-9 and miR-132 in embryonic mouse neocortex: implications for radial migration of neurons. Development (Cambridge, England) 2012, 139:3332-3342.
16. Cogswell J.P., Ward J., Taylor I.A., Waters M., Shi Y., Cannon B., Kelnar K., Kemppainen J., Brown D., Chen C., Prinjha R.K., Richardson J.C., Saunders A.M., Roses A.D., Richards C.A. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. Journal of Alzheimer's disease: JAD 2008, 14:27-41.
17. Derrien T., Johnson R., Bussotti G., Tanzer A., Djebali S., Tilgner H., Guernec G., Martin D., Merkel A., Knowles D.G., Lagarde J., Veeravalli L., Ruan X., Ruan Y., Lassmann T., Carninci P., Brown J.B., Lipovich L., Gonzalez J.M., Thomas M., Davis C.A., Shiekhattar R., Gingeras T.R., Hubbard T.J., Notredame C., Harrow J., Guigo R. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Research 2012, 22:1775-1789.
18. Dickson J.R., Kruse C., Montagna D.R., Finsen B., Wolfe M.S. Alternative polyadenylation and miR-34 family members regulate tau expression. Journal of Neurochemistry 2013, 127:739-749.
19. Faghihi M.A., Modarresi F., Khalil A.M., Wood D.E., Sahagan B.G., Morgan T.E., Finch C.E., St Laurent G., Kenny P.J., Wahlestedt C. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nature Medicine 2008, 14:723-730.
20. Geekiyanage H., Jicha G.A., Nelson P.T., Chan C. Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. Experimental Neurology 2011, 235:491-496.
21. Goodall E.F., Heath P.R., Bandmann O., Kirby J., Shaw P.J. Neuronal dark matter: the emerging role of microRNAs in neurodegeneration. Frontiers in Cellular Neuroscience 2013, 7:178.
22. Guerreiro R.J., Hardy J. Alzheimer's disease genetics: lessons to improve disease modelling. Biochemical Society Transactions 2011, 39:910-916.
23. Haghikia A., Hellwig K., Baraniskin A., Holzmann A., Decard B.F., Thum T., Gold R. Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study. Neurology 2012, 79:2166-2170.
24. Hansen K.F., Karelina K., Sakamoto K., Wayman G.A., Impey S., Obrietan K. miRNA-132: a dynamic regulator of cognitive capacity. Brain Structure & Function 2013, 218:817-831.
25. Hebert S.S., Horre K., Nicolai L., Papadopoulou A.S., Mandemakers W., Silahtaroglu A.N., Kauppinen S., Delacourte A., De Strooper B. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:6415-6420.
26. Hebert S.S., Wang W.X., Zhu Q., Nelson P.T. A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. Journal of Alzheimer's disease: JAD 2013, 35:335-348.
27. Hunter M.P., Ismail N., Zhang X., Aguda B.D., Lee E.J., Yu L., Xiao T., Schafer J., Lee M.L., Schmittgen T.D., Nana-Sinkam S.P., Jarjoura D., Marsh C.B. Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 2008, 3:e3694.
28. Kirschner M.B., Kao S.C., Edelman J.J., Armstrong N.J., Vallely M.P., van Zandwijk N., Reid G. Haemolysis during sample preparation alters microRNA content of plasma. PLoS ONE 2011, 6:e24145.
29. Kumar P., Dezso Z., MacKenzie C., Oestreicher J., Agoulnik S., Byrne M., Bernier F., Yanagimachi M., Aoshima K., Oda Y. Circulating miRNA biomarkers for Alzheimer's disease. PLoS ONE 2013, 8:e69807.
30. Lambert J.C., Ibrahim-Verbaas C.A., Harold D., Naj A.C., Sims R., Bellenguez C., Jun G., Destefano A.L., Bis J.C., Beecham G.W., Grenier-Boley B., Russo G., Thornton-Wells T.A., Jones N., Smith A.V., Chouraki V., Thomas C., Ikram M.A., Zelenika D., Vardarajan B.N., Kamatani Y., Lin C.F., Gerrish A., Schmidt H., Kunkle B., Dunstan M.L., Ruiz A., Bihoreau M.T., Choi S.H., Reitz C., Pasquier F., Hollingworth P., Ramirez A., Hanon O., Fitzpatrick A.L., Buxbaum J.D., Campion D., Crane P.K., Baldwin C., Becker T., Gudnason V., Cruchaga C., Craig D., Amin N., Berr C., Lopez O.L., De Jager P.L., Deramecourt V., Johnston J.A., Evans D., Lovestone S., Letenneur L., Moron F.J., Rubinsztein D.C., Eiriksdottir G., Sleegers K., Goate A.M., Fievet N., Huentelman M.J., Gill M., Brown K., Kamboh M.I., Keller L., Barberger-Gateau P., McGuinness B., Larson E.B., Green R., Myers A.J., Dufouil C., Todd S., Wallon D., Love S., Rogaeva E., Gallacher J., St George-Hyslop P., Clarimon J., Lleo A., Bayer A., Tsuang D.W., Yu L., Tsolaki M., Bossu P., Spalletta G., Proitsi P., Collinge J., Sorbi S., Sanchez-Garcia F., Fox N.C., Hardy J., Naranjo M.C., Bosco P., Clarke R., Brayne C., Galimberti D., Mancuso M., Matthews F., Moebus S., Mecocci P., Del Zompo M., Maier W., Hampel H., Pilotto A., Bullido M., Panza F., Caffarra P., Nacmias B., Gilbert J.R., Mayhaus M., Lannfelt L., Hakonarson H., Pichler S., Carrasquillo M.M., Ingelsson M., Beekly D., Alvarez V., Zou F., Valladares O., Younkin S.G., Coto E., Hamilton-Nelson K.L., Gu W., Razquin C., Pastor P., Mateo I., Owen M.J., Faber K.M., Jonsson P.V., Combarros O., O'Donovan M.C., Cantwell L.B., Soininen H., Blacker D., Mead S., Mosley T.H., Bennett D.A., Harris T.B., Fratiglioni L., Holmes C., de Bruijn R.F., Passmore P., Montine T.J., Bettens K., Rotter J.I., Brice A., Morgan K., Foroud T.M., Kukull W.A., Hannequin D., Powell J.F., Nalls M.A., Ritchie K., Lunetta K.L., Kauwe J.S., Boerwinkle E., Riemenschneider M., Boada M., Hiltunen M., Martin E.R., Schmidt R., Rujescu D., Wang L.S., Dartigues J.F., Mayeux R., Tzourio C., Hofman A., Nothen M.M., Graff C., Psaty B.M., Jones L., Haines J.L., Holmans P.A., Lathrop M., Pericak-Vance M.A., Launer L.J., Farrer L.A., van Duijn C.M., Van Broeckhoven C., Moskvina V., Seshadri S., Williams J., Schellenberg G.D., Amouyel P. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nature Genetics 2013, 45:1452-1458.
31. Lau P., Bossers K., Janky R., Salta E., Frigerio C.S., Barbash S., Rothman R., Sierksma A.S., Thathiah A., Greenberg D., Papadopoulou A.S., Achsel T., Ayoubi T., Soreq H., Verhaagen J., Swaab D.F., Aerts S., De Strooper B. Alteration of the microRNA network during the progression of Alzheimer's disease. EMBO Molecular Medicine 2013, 5:1613-1634.
32. Lau P., De Strooper B. Dysregulated microRNAs in neurodegenerative disorders. Seminars in Cell & Developmental Biology 2010, 21:768-773.
33. Lehmann S.M., Kruger C., Park B., Derkow K., Rosenberger K., Baumgart J., Trimbuch T., Eom G., Hinz M., Kaul D., Habbel P., Kalin R., Franzoni E., Rybak A., Nguyen D., Veh R., Ninnemann O., Peters O., Nitsch R., Heppner F.L., Golenbock D., Schott E., Ploegh H.L., Wulczyn F.G., Lehnardt S. An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nature Neuroscience 2012, 15:827-835.
34. Leidinger P., Backes C., Deutscher S., Schmitt K., Mueller S.C., Frese K., Haas J., Ruprecht K., Paul F., Stahler C., Lang C.J., Meder B., Bartfai T., Meese E., Keller A. A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biology 2013, 14:R78.
35. Luikart B.W., Bensen A.L., Washburn E.K., Perederiy J.V., Su K.G., Li Y., Kernie S.G., Parada L.F., Westbrook G.L. miR-132 mediates the integration of newborn neurons into the adult dentate gyrus. PLoS ONE 2011, 6:e19077.
36. Lukiw W.J. Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. NeuroReport 2007, 18:297-300.
37. Lukiw W.J., Handley P., Wong L., Crapper McLachlan D.R. BC200 RNA in normal human neocortex, non-Alzheimer dementia (NAD), and senile dementia of the Alzheimer type (AD). Neurochemical Research 1992, 17:591-597.
38. Magill S.T., Cambronne X.A., Luikart B.W., Lioy D.T., Leighton B.H., Westbrook G.L., Mandel G., Goodman R.H. microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:20382-20387.
39. Mestdagh P., Van Vlierberghe P., De Weer A., Muth D., Westermann F., Speleman F., Vandesompele J. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biology 2009, 10:R64.
40. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., Peterson A., Noteboom J., O'Briant K.C., Allen A., Lin D.W., Urban N., Drescher C.W., Knudsen B.S., Stirewalt D.L., Gentleman R., Vessella R.L., Nelson P.S., Martin D.B., Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:10513-10518.
41. Muller M., Kuiperij H.B., Claassen J.A., Kusters B., Verbeek M.M. MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid. Neurobiology of Aging 2014, 35:152-158.
42. Mus E., Hof P.R., Tiedge H. Dendritic BC200 RNA in aging and in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:10679-10684.
43. Nudelman A.S., DiRocco D.P., Lambert T.J., Garelick M.G., Le J., Nathanson N.M., Storm D.R. Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo. Hippocampus 2010, 20:492-498.
44. Nunez-Iglesias J., Liu C.C., Morgan T.E., Finch C.E., Zhou X.J. Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PLoS ONE 2010, 5:e8898.
45. Parenti R., Paratore S., Torrisi A., Cavallaro S. A natural antisense transcript against Rad18, specifically expressed in neurons and upregulated during beta-amyloid-induced apoptosis. European Journal of Neuroscience 2007, 26:2444-2457.
46. Pritchard C.C., Cheng H.H., Tewari M. MicroRNA profiling: approaches and considerations. Nature Reviews Genetics 2012, 13:358-369.
47. Remenyi J., van den Bosch M.W., Palygin O., Mistry R.B., McKenzie C., Macdonald A., Hutvagner G., Arthur J.S., Frenguelli B.G., Pankratov Y. miR-132/212 knockout mice reveal roles for these miRNAs in regulating cortical synaptic transmission and plasticity. PLoS ONE 2013, 8:e62509.
48. Sala Frigerio C., Lau P., Salta E., Tournoy J., Bossers K., Vandenberghe R., Wallin A., Bjerke M., Zetterberg H., Blennow K., De Strooper B. Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease. Neurology 2013, 81:2103-2106.
49. Sauvageau M., Goff L.A., Lodato S., Bonev B., Groff A.F., Gerhardinger C., Sanchez-Gomez D.B., Hacisuleyman E., Li E., Spence M., Liapis S.C., Mallard W., Morse M., Swerdel M.R., D'Ecclessis M.F., Moore J.C., Lai V., Gong G., Yancopoulos G.D., Frendewey D., Kellis M., Hart R.P., Valenzuela D.M., Arlotta P., Rinn J.L. Multiple knockout mouse models reveal lincRNAs are required for life and brain development. eLife 2013, 2:e01749.
50. Schipper H.M., Maes O.C., Chertkow H.M., Wang E. MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regulation and Systems Biology 2007, 1:263-274.
51. Schonrock N., Gotz J. Decoding the non-coding RNAs in Alzheimer's disease. Cellular and Molecular Life Sciences: CMLS 2012, 69:3543-3559.
52. Shaked I., Meerson A., Wolf Y., Avni R., Greenberg D., Gilboa-Geffen A., Soreq H. MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity 2009, 31:965-973.
53. Sheinerman K.S., Tsivinsky V.G., Crawford F., Mullan M.J., Abdullah L., Umansky S.R. Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging (Albany, NY) 2012, 4:590-605.
54. Smith P.Y., Delay C., Girard J., Papon M.A., Planel E., Sergeant N., Buee L., Hebert S.S. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy. Human Molecular Genetics 2011, 20:4016-4024.
55. Sperling R., Beckett L., Bennett D., Craft S., Fagan A., Kaye J., Montine T., Park D., Reiman E., Siemers E., Stern Y., Yaffe K. Criteria for Preclinical Alzheimer's Disease 2010, Alzheimer's Association.
56. Strum J.C., Johnson J.H., Ward J., Xie H., Feild J., Hester A., Alford A., Waters K.M. MicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1. Molecular Endocrinology (Baltimore, MD) 2009, 23:1876-1884.
57. Sun A.X., Crabtree G.R., Yoo A.S. MicroRNAs: regulators of neuronal fate. Current Opinion in Cell Biology 2013, 25:215-221.
58. Talkowski M.E., Maussion G., Crapper L., Rosenfeld J.A., Blumenthal I., Hanscom C., Chiang C., Lindgren A., Pereira S., Ruderfer D., Diallo A.B., Lopez J.P., Turecki G., Chen E.S., Gigek C., Harris D.J., Lip V., An Y., Biagioli M., Macdonald M.E., Lin M., Haggarty S.J., Sklar P., Purcell S., Kellis M., Schwartz S., Shaffer L.G., Natowicz M.R., Shen Y., Morton C.C., Gusella J.F., Ernst C. Disruption of a large intergenic noncoding RNA in subjects with neurodevelopmental disabilities. American Journal of Human Genetics 2012, 91:1128-1134.
59. Ulitsky I., Bartel D.P. lincRNAs: genomics, evolution, and mechanisms. Cell 2013, 154:26-46.
60. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology 2007, 9:654-659.
61. van Harten A., Mulders J., Çevik C., Kester M., Scheltens P., Flier W., Oudejans C. MicroRNA analysis in the spinal fluid of alzheimer patients: a methodological feasibility study. Circulating Nucleic Acids in Plasma and Serum 2011, 275-282. Springer, Netherlands.
62. Vickers K.C., Palmisano B.T., Shoucri B.M., Shamburek R.D., Remaley A.T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nature Cell Biology 2011, 13:423-433.
63. Vo N., Klein M.E., Varlamova O., Keller D.M., Yamamoto T., Goodman R.H., Impey S. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:16426-16431.
64. Wanet A., Tacheny A., Arnould T., Renard P. miR-212/132 expression and functions: within and beyond the neuronal compartment. Nucleic Acids Research 2012, 40:4742-4753.
65. Wang K., Zhang S., Weber J., Baxter D., Galas D.J. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Research 2010, 38:7248-7259.
66. Wang W.X., Huang Q., Hu Y., Stromberg A.J., Nelson P.T. Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathologica 2011, 121:193-205.
67. Wang W.X., Rajeev B.W., Stromberg A.J., Ren N., Tang G., Huang Q., Rigoutsos I., Nelson P.T. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2008, 28:1213-1223.
68. Wong H.K., Veremeyko T., Patel N., Lemere C.A., Walsh D.M., Esau C., Vanderburg C., Krichevsky A.M. De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease. Human Molecular Genetics 2013, 22:3077-3092.